## Structural Distinction Between HBV and HCV ### Viral Structure Comparison | Feature | Hepatitis B | Hepatitis C | |---------|-------------|-------------| | **Genome** | Double-stranded DNA (dsDNA) | Single-stranded RNA (ssRNA) | | **Envelope** | Yes (lipid bilayer) | Yes (lipid bilayer) | | **Surface Antigen** | HBsAg (embedded in envelope) | No equivalent surface antigen | | **Envelope Protein** | HBsAg, HBeAg | E1, E2 glycoproteins | | **Mutation Rate** | Low (DNA polymerase fidelity) | Very high (RNA-dependent RNA polymerase) | | **Virion Size** | 42 nm (Dane particle) | 50–65 nm | **Key Point:** HBV is an enveloped DNA virus with HBsAg as its defining surface antigen, whereas HCV is an enveloped RNA virus with E1/E2 glycoproteins but NO HBsAg equivalent. ### Why This Matters Clinically **High-Yield:** The presence of HBsAg in the lipid envelope of HBV is the diagnostic hallmark and forms the basis of serological screening. HCV lacks this surface antigen; diagnosis relies on anti-HCV antibodies and HCV RNA detection. **Clinical Pearl:** HBV's lower mutation rate (due to DNA polymerase proofreading) allows vaccine development; HCV's high mutation rate (quasi-species formation) has historically made vaccine development challenging. ### Genome Implications 1. **HBV (dsDNA):** Reverse transcription step in replication; integration into host genome possible → chronic carriage with integrated viral DNA. 2. **HCV (ssRNA):** Direct RNA-dependent replication; no integration; but rapid mutation → immune escape → chronic infection despite antibody response.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.